Sarah Cannon Research Institute Harbinger Health Joins Emerging Multi-Cancer Screening Arena With Tech Focused On Oncogenesis Premium The company recently signed a partnership with Sarah Cannon to conduct a 10,000-patient clinical study to further validate its experimental assay. Sarah Cannon Cancer Institute Acquires Genospace The cloud-based personalized medicine software company will stay in Cambridge, Massachusetts and will become a wholly-owned subsidiary of the institute. Foundation Medicine, Sarah Cannon Partner on Genomic Profiling for Cancer Clinical Trials Under the agreement, researchers can use Foundation Medicine's assays to select patients eligible for Sarah Cannon Research Institute's clinical studies. Drugmakers Increasingly Using Basket Trials to Gain Precision Medicine Insights, ASCO Studies Show Premium Researchers presented data suggesting that pharma companies are using basket studies to identify molecularly defined patient subsets who might benefit from their drugs. Biocept, Sarah Cannon Partner for Breast Cancer Screening The partners will explore the use of Biocept's liquid biopsy technology to identify and detect biomarkers in ER-positive breast cancer patients. Jun 4, 2014 At ASCO, Growing Data from NGS-guided Cancer Therapy Programs Premium Jul 3, 2013 With Sarah Cannon Research Institute, AstraZeneca Genomically Profiling Patients for Drug Trials Premium Jul 1, 2013 Sarah Cannon Inks Personalized Medicine Pact with AstraZeneca May 8, 2013 UCL-AD, Sarah Cannon to Launch Cancer Panel on PGM to Select Therapy, Stratify Patients for Trials Premium Oct 17, 2012 Prospective Study Suggests Site-Specific Treatment after BioTheranostics' CUP Testing Improves Survival Premium Breaking News Plasmid Transfer Let Cholera Pathogen in Yemen Become Multidrug Resistant, Study Suggests Harbinger Health Raises $140 Million in Series B Financing BioMérieux's BioFire Defense Secures $18.8M US DoD Contract for Infectious Disease Testing Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.